# "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

> **NCT00214656** · PHASE3 · UNKNOWN · sponsor: **Austin Health** · enrollment: 40 (—)

## Conditions studied

- Myocardial Ischemia
- Blood Coagulation Disorders
- Coronary Artery Disease
- Heart Valve Diseases

## Interventions

- **DRUG:** Recombinant Activated Factor VII

## Key facts

- **NCT ID:** NCT00214656
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214656, ""Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00214656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*